Patients with drug-abuse poisoning with and without HIV infection: differential characteristics.  Losada A, Supervía A, Vallecillo G, Petrus C, Aranda D, Chen J, Saubi N, Pallàs O, Perelló R.  Emergencias. 2023 Apr;35(2):103-108. Spanish…

Peer recovery coaching for comprehensive HIV, hepatitis C, and opioid use disorder management: The CHORUS pilot study.  Martin AK, Perryman T, Bernstein JA, Taylor JL, Cruz R, Muroff J, Samet JH, Assoumou SA.  Drug Alcohol Depend Rep. 20…

HIV and HCV among drug users and people living in prisons in Germany 2022: WHO elimination targets as reflected in practice.  Stöver, H., Dichtl, A., Schäffer, D. et al. Harm Reduct J 20, 50 (2023). https://doi.org/10.1186/s12954-02…

Aidshilfe sieht mehr Potenzial bei Prä-Expositions-Prophylaxe Bonn – Die medikamentöse HIV-Prophylaxe ist erfolgreich, ihr Potenzial jedoch bei Weitem nicht ausgeschöpft. In einem neuen Positionspapier fordert die Deutsche Aidshilfe (DAH) bessere A…

HIV and Addiction Services for People Who Inject Drugs: Healthcare Provider Perceptions on Integrated Care in the U.S. South.  Bradford D, Parman M, Levy S, Turner WH, Li L, Leisch L, Eaton E, Crockett KB.  J Prim Care Community Health…

Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort study Isfordink, Cas J et al. The Lancet Public Health, Volume 8, Issue 4…